China's MegaRobo Raises Nearly $200 Million as Oman's Wealth Fund Backs AI-Run Labs
The Suzhou lab-automation company has now raised about $600 million, and says it will use the new money to take its AI for Science business abroad.

What to know
- MegaRobo Technologies raised nearly $200 million in a round joined by the Oman Investment Authority, with CMB International investing for the first time.
- The round lifts the Suzhou company's total funding to about $600 million, including an equity round of about $300 million in 2022 co-led by Goldman Sachs.
- MegaRobo says it has sold products to more than 500 customers and that its Megalaxy Lab service has served more than 200; it did not disclose a valuation.
HONG KONG
MegaRobo Technologies, a Chinese company that builds robotic laboratories run partly by artificial intelligence, has raised nearly $200 million in a new funding round joined by the Oman Investment Authority, the Gulf state's sovereign wealth fund. The company announced the deal late on Wednesday, New York time, which was Thursday morning in China.
The round puts a Gulf sovereign investor on the shareholder list of a Chinese AI and robotics company that already counts Goldman Sachs and a Temasek-linked fund among its backers. MegaRobo said it has now raised about $600 million in total. It did not disclose a valuation, and neither The Next Web nor Tech Startups reported one.
MegaRobo's investors and the new money
Existing shareholders Asia Investment Capital, Granite Asia and Sinovation Ventures put in more money, and CMB International joined as a new investor, according to the company's announcement, which carried a Suzhou dateline. The release did not name a lead investor or give the round a series letter.
MegaRobo said the money will go into its core technology, overseas growth for what it calls its AI for Science business, and systems that let AI operate in more complex physical settings. It plans to keep expanding across North America, Europe, the Middle East and Asia.
The last big check came in June 2022, when MegaRobo announced a Series C of about $300 million in a release from Beijing. That release named Goldman Sachs Asset Management, Asia Investment Capital and GGV Capital as co-leads, with Sinovation Ventures, Pavilion Capital and Starr Capital among the other backers. The new release describes Pavilion Capital as part of Temasek's Seviora Group. This week's release lists Granite Asia in GGV's place as a co-lead of that round and adds that WuXi AppTec and Bosch Ventures invested at earlier stages.
Liu Erh Fei, founding partner and chief executive of Asia Investment Capital, said in the release that the company's mix of AI, software and hardware, along with its record in research and manufacturing, was behind his firm's decision to keep investing.
According to the news site Tech Startups, MegaRobo also serves industrial customers in semiconductor and display manufacturing, where it helps diagnose process defects and lift yields. The company's own release did not mention those customers and focused on drug research.
From pipetting robots to an "intelligence stack"
MegaRobo started out selling automation to life sciences labs. Its 2022 release described products ranging from benchtop workflow tools to fully automated platforms used in antibody selection, cell line development, gene editing and COVID-19 testing, and said it had offered such systems since 2016.
The company now pitches itself in broader terms. Its main product, which it calls the One Intelligence Stack, links AI models and software with lab instruments, robots and data so that a system can plan an experiment, run it and learn from the result. Drug discovery is the first market. MegaRobo says it has delivered products to more than 500 customers, including global drugmakers, biotech companies and research institutes, and that its systems are used in target discovery, drug screening and candidate optimization.
A newer service, Megalaxy Lab, lets researchers and AI agents send experiments to automated labs and get back machine-readable results. The company says it has served more than 200 customers. The Next Web attributed the customer figures to the company, and The AI Insider reported the same numbers.
Founder and Chief Executive Daniel Huang said the next generation of AI will learn by acting in the physical world, a change he said turns AI into something that "can help create new knowledge."
The company has also started a public test of the idea. With Tencent Cloud and DNA synthesis company Twist Bioscience, it launched Poreva Open, an international protein design contest open to any AI model. Megalaxy Lab will run wet-lab tests on more than 10,000 designed protein sequences, the company said, with the aim of building a common benchmark for AI-designed proteins.
A busy month for Chinese hard-tech rounds
The deal adds to a run of large rounds for Chinese companies that apply AI to physical work. Suzhou-based UniX AI, which makes wheeled humanoid robots for security, hotels and retail, raised 500 million yuan (about $75 million) in a pre-Series A round, The AI Insider reported on Nov. 17, citing Science and Technology Daily. Greenland Group, a customer, joined that round as a strategic investor, according to the report.
Capital Times has covered GenRobot's $100 million round for robot training data and third-quarter startup funding across Asia.
MegaRobo's pitch differs from the humanoid makers in one respect: its first customers are scientists, not factories or shops, and most of the more than 500 customers it cites are drugmakers, biotech companies and research labs, The Next Web reported. The Next Web placed the round alongside other large bets on AI drug design, including Isomorphic Labs, the Alphabet company it said raised $5 billion on Tuesday, and Chai Discovery, which it said raised $400 million in July.
The company did not say when it expects to turn a profit or whether it plans to list shares. The next public marker is Poreva Open, where the lab results for more than 10,000 AI-designed proteins will show how well the system works outside a press release.
Sources
- MegaRobo Technologies via PR Newswire: MegaRobo Raises Nearly US$200 Million in New Funding to Build Intelligence Infrastructure for the Physical World (Nov. 18, 2026)
- The Next Web: MegaRobo raises nearly $200M to let AI run real lab experiments (Nov. 19, 2026)
- The AI Insider: MegaRobo Raises Nearly $200M to Fund Expansion of AI-Powered Laboratory Automation (Nov. 19, 2026)
- Tech Startups: Startup Funding News Today, November 19, 2026 (Nov. 19, 2026)
- MegaRobo Technologies via PR Newswire: MegaRobo Technologies Completed US$300mm Series C Financing (June 15, 2022)
- The AI Insider: China Physical AI Roundup: UniX AI Raises $75M Pre-A (Nov. 17, 2026)
Our standards: Capital Times reports under the principles set out in our Editorial Standards and Ethics Policy. Spotted an error? Report it to our editors.







